公司资料

Agilon Health 股价、新闻与催化剂

股票代码:
AGL
交易所:
NYSE
行业:
Biopharma
所在地:
United States

股票表现

96.86 USD (-0.04%)

收盘价

最后更新: 2026年8月17日

1.45B USD

市值

股价为何变动

As of Aug 17, 2026, AGL was little changed and closed at $96.86. No new same-company headline was identified in the current news window.

公司概览

业务概览

agilon health is a healthcare services company focused on value-based care for senior patients through physician partnerships. Its business centers on care coordination, risk management, and primary-care economics rather than biotech innovation.

所在地与行业分类

Headquartered in the United States and listed on NYSE, agilon is a U.S.-focused healthcare services name. It sits in value-based care rather than biotechnology.

商业模式特征

The company generates revenue through care management relationships, risk-based contracts, and physician-aligned healthcare delivery. Investors focus on medical-cost ratios, membership growth, and the economics of its senior-care model.

生物医药行业定位

agilon health is outside biotech, but it belongs to the broader healthcare services landscape that shapes how patients access care. Its stock moves on utilization and execution, not on drug approvals.

未来催化剂

  • agilon health’s catalysts are membership quality, medical-cost trends, and evidence that the MA platform can get back on firmer footing. The next update will help show whether the company is moving from promise to a more de-risked stage of execution. Investors will care less about the label than about whether the platform can keep producing credible next steps.

近期新闻

    相似股票

    商业成熟度、治疗领域或催化剂模式相近的同行公司。